Retained Products. Ampliphi shall be permitted to continue the development and Commercialization in the Field of any product resulting from the Bacteriophage Program that, at the time of termination, satisfies at least one of the following criteria (a “Retained Product”):
Appears in 4 contracts
Samples: Channel Collaboration Agreement (AmpliPhi Biosciences Corp), Collaboration Agreement (AmpliPhi Biosciences Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp)